Solutions Drug Updates Drug News Support Contact Us

 

 

 

 

 

 

 

Idursulfase for intravenous infusion

ELAPRASE

 

FDA Approval: July 2006
Indication: Hunter syndrome (Mucopolysaccaridosis II)
Pharmacology: Recombinant human iduronate-2-sulfatase
Usual Dose: 0.5 mg/kg by IV infusion once a week
Contraindications: none
Warnings:

Severe and life-threatening hypersensitivity reactions have occurred during infusion, including anaphylactoid reactions, respiratory distress, hypoxia, hypotension, angioedema, seizures, cyanosis. 

Patients with acute respiratory disease or compromised respiratory function may have a greater risk of developing life-threatening complications.  Deferring infusion should be considered in patients with acute respiratory or febrile illnesses.

Caution recommended during lactation

Safety and effectiveness not established in patients younger than 5 years

Pregnancy Category: C
Side Effects: Infusion reactions, hypoxia, cardiac arrhythmia, pulmonary embolism, cyanosis, respiratory failure, infection, arthralgia

Pyrexia, headache, arthralgia, limb pain, pruritus, hypertension, malaise, visual disturbances, wheezing, abscess, musculoskeletal dysfunction, chest wall pain, urticaria, injury, anxiety, irritability, atrial abnormality, dyspepsia, infusion site edema, skin disorder, pruritic rash, development of anti-idursulfase antibodies

Drug Interactions: unknown



Every effort has been made to ensure that the information provided by Cerner Multum, Inc. (“Multum”) is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and end-users in the United States. Cerner Multum does not warrant that uses outside of the United States are appropriate.
Multum’s drug information does not endorse drugs, diagnose patients or recommend therapy. Multum’s drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve end-users viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. Healthcare practitioners should use their professional judgment in using the information provided. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient.
Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides.
The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2006-2007 Cerner Multum, Inc.


 

Home  Products  Client Support